Alon Weizer, MD
Urology · Miami Beach, FLNPI 1114019585
Payments from drug & device makers
Across 45 payments — averaging $407.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogen Pharma, Inc.$16K
- Boston Scientific$384
- Coloplast$331
- Novo Nordisk$240
- Myriad Genetic Laboratories, Inc.$229
- Procept Biorobotics Corporation$160
- plus $1K from 14 others
Across 1 payment — averaging $352.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urogen Pharma, Inc.$352
What the payments were for
- Food & beverage$3,022100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogen Pharma, Inc. | 13 | $15,868 |
| Boston Scientific | 4 | $384 |
| Coloplast | 4 | $331 |
| Novo Nordisk | 3 | $240 |
| Myriad Genetic Laboratories, Inc. | 2 | $229 |
| Procept Biorobotics Corporation | 1 | $160 |
| Pfizer | 2 | $157 |
| Heartflow, Inc. | 1 | $148 |
| Immunitybio, Inc. | 1 | $146 |
| Dendreon Pharmaceuticals LLC | 2 | $145 |
| Bioprotect Medical, Inc. | 1 | $135 |
| Laborie Medical Technologies Corp. | 2 | $110 |
| Teleflex LLC | 1 | $84 |
| Johnson & Johnson | 2 | $59 |
| Diagnostica Stago, Inc | 1 | $30 |
| Viiv Healthcare Company | 1 | $29 |
| Intuitive Surgical | 1 | $29 |
| Novartis | 1 | $24 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $23 |
| Olympus America Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JELMYTO$366
- TITAN$276
- Prolaris$194
- AquaBeam Robotic System$160
- SpaceOAR VUE System - 10mL$158
- FFRct$148
- ANKTIVA$146
- BIOPROTECT BALLOON IMPLANT SYSTEM$135
- PROVENGE$129
- rezum Generator$117
- GreenLight XPS$100
How this compares
$18,345 in reported general payments places this provider in the 80th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 14 | $990 |
| Tamsulosin Hcl | 36 | $205 |
| Ciprofloxacin Hcl | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other urology in Miami Beach
- Steven KesterPompano Beach$5.7M
- Harvey SamowitzHallandale Beach$3.6M
- Paul PeritoCoral Gables$3.6M
- Graham GreeneLakeland$2.5M
- Scott SellingerTallahassee$2.3M
- Fernando BiancoHialeah$2.2M
- Osvaldo PadronTampa$1.3M
- Mark Anthony GonzalgoMiami$1.1M
- Paul CrispenGainesville$1.1M
- Craig HermanPompano Beach$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.